3,3',4'-trihydroxyflavone has been researched along with Ventricular Dysfunction, Left in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Connelly, KA; Edgley, AJ; Kelly, DJ; Khong, FL; Krum, H; Qi, W; Woodman, OL; Zhang, Y | 1 |
1 other study(ies) available for 3,3',4'-trihydroxyflavone and Ventricular Dysfunction, Left
Article | Year |
---|---|
3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats.
Topics: Animals; Antioxidants; Autoradiography; Cardiac Catheterization; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Flavonols; Homozygote; In Situ Hybridization; Male; NADPH Oxidases; Oxidative Stress; Rats; Rats, Transgenic; Reactive Oxygen Species; Ventricular Dysfunction, Left | 2011 |